Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Genes May Predict Response to Sole Sickle Cell Drug

Published: Friday, February 22, 2013
Last Updated: Friday, February 22, 2013
Bookmark and Share
Only one drug is currently available under FDA regulations, but response varies greatly from patient to patient.

Hydoxyurea is an almost ideal drug for many children with sickle cell anemia. It reduces the severe pain and long-term organ damage caused by sickled blood cells; it can improve lifespan; and it is cheap and fairly safe. And it’s the only FDA-approved medication for sickle cell anemia.

What’s not ideal is the variable response to the drug. “Right now, you just don’t know what’s going to happen when you start a patient on hydroxyurea,” said Nancy Green, MD, associate professor of pediatrics. “Some have only a modest response, while for others, the drug changes the disease, keeps them out of the hospital, and gets them back to their lives.”

“If the drug isn’t going to do much for a patient, we want to know so we can start thinking about other options, blood transfusions or a bone marrow transplant, that are not as easy or readily available.”

Genetic differences among patients undoubtedly play a role. With the help of a consortium she organized—with researchers from Albert Einstein, Weill-Cornell, Yale, Oakland Children’s, and the University of Rochester—Green is now starting to identify genes that eventually may help physicians better predict response to hydroxyurea.

In sickle cell disease, a mutation in the hemoglobin gene causes the hemoglobin molecules inside red blood cells to stick to each other. When that happens, the cells become damaged and lose their flexibility, causing them to assume a sickle shape. If patients also produce enough fetal hemoglobin—normally produced only in very small amounts after birth—more red blood cells retain their normal round shape and flow through the microvasculature throughout the body. Hydroxyurea works in large part because it increases the production of fetal hemoglobin, thereby reducing sickling and its complications.

The amount of fetal hemoglobin patients can produce on their own is often an indication of the degree to which they will respond to the drug, but not always. Many patients with high baseline levels fail to mount a large fetal hemoglobin response to the drug, while fetal hemoglobin sometimes surges even in patients with low baseline levels.

A recent study published by Green and her colleagues in PloS One looked at predictors of hydroxyurea response in 117 children and found that baseline levels of fetal hemoglobin explain 33 percent of the variation in patient response.

That percentage increased to almost 50 percent when the researchers factored in each patient’s type of epsilon globin gene. Green and her team also found other genes that seem to be linked to the fetal hemoglobin response to drug, but those will need to be investigated in future studies with more patients.

“Our genetic results still need to be confirmed by other researchers, and we need to find the factors that control the other 50 percent of the variation in response, but I think we will soon get to a point when we can more reliably predict who will do well on hydroxyurea,” Green said.

“With a prediction tool, we could identify patients who should benefit but aren’t because of difficulty adhering to the daily regimen. And we could offer the drug earlier to those who are most likely to respond,” she said.

“For many children with sickle cell disease, the earlier they start using hydroxyurea, the greater impact it will have on their lives.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GI Problems in Autism May Originate in Genes
Gene linked to autism lowers serotonin activity in mice, slows movement in gut.
Tuesday, April 26, 2016
Virus Causing Tilapia Die-Offs Identified
Discovery of the virus causing Tilapia die-offs in Israel and Ecuador points the way to protecting a fish that feeds multitudes.
Wednesday, April 06, 2016
Celiac Disease Risk Linked to Non-coding RNA
Suggests factors outside of protein-coding genes play a role in celiac disease.
Friday, April 01, 2016
New Haploid Embryonic Stem Cell Line
The haploid stem cells may yield new genetic screening tools and therapies.
Thursday, March 17, 2016
Core Symptom of Schizophrenia Eliminated
Team uses chemical compound to restore affected brain regions; findings could lead to new treatment strategies.
Friday, February 19, 2016
New Way to Identify Brain Tumor Aggressiveness
Looking at a brain tumor’s epigenetic signature may help guide therapy.
Friday, January 29, 2016
Useful Colon Cancer Biomarker Discovered
Biomarker is detectable with simple, inexpensive test.
Monday, January 25, 2016
Link Between Congenital Heart, Brain Disorders
Tools of precision medicine may lead to earlier identification and treatment of children with neurodevelopmental disorders.
Thursday, December 10, 2015
Engineers Build Biologically Powered Chip
System combines biological ion channels with solid-state transistors to create a new kind of electronics.
Wednesday, December 09, 2015
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Thursday, November 26, 2015
What Do Animal Viruses Have to Do with Human Health?
Simon Anthony studies animal infections to prevent outbreaks in people.
Monday, September 28, 2015
Dentists Tapped for New Role: Drug Screenings
A visit to the dentist has the potential to be more than a checkup of our teeth as patients are increasingly screened for medical conditions like heart disease and diabetes.
Tuesday, August 18, 2015
Computer Model Forecasts Flu Outbreaks in Subtropical Climate
Study in Hong Kong predicts outbreaks by flu strains and is first to forecast flu in a subtropical climate.
Friday, August 07, 2015
Long-term Memories Are Maintained by Prion-like Proteins
Research from Eric Kandel’s lab at Columbia University Medical Center has uncovered evidence of a system in the brain that persistently maintains memories for long periods of time.
Friday, July 03, 2015
Scientists are Designing Decoy Drugs to Fool Cancer
Study shows potential of drugs that can target the Notch switch with reduced toxicity.
Thursday, May 28, 2015
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
Nanoparticles Target, Transform Fat Tissue
Nanoparticles designed to target white fat and convert it to calorie-burning brown fat slowed weight gain in obese mice without affecting food intake. This proof-of-concept work could lead to new therapies to treat obesity.
New Cancer Fighters Emerge From Lab
Rice University lab simplifies total synthesis of anti-cancer agent.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!